• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

跨物种病毒传播及其大流行潜力。

Cross-species virus transmission and its pandemic potential.

作者信息

Choudhury Priyanka Ray, Saha Tapoja, Goel Sachin, Shah Janvi Manish, Ganjewala Deepak

机构信息

Amity Institute of Biotechnology, Amity University Noida, Sector 125, Noida, 201303 India.

Department of Biotechnology, Noida Institute of Engineering and Technology, 19, Knowledge Park-II, Institutional Area, Greater Noida, 201306 India.

出版信息

Bull Natl Res Cent. 2022;46(1):18. doi: 10.1186/s42269-022-00701-7. Epub 2022 Jan 25.

DOI:10.1186/s42269-022-00701-7
PMID:35095263
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8787036/
Abstract

BACKGROUND

The majority of pandemics are known to be a result of either bacteria or viruses out of which viruses seem to be an entity of growing concern due to the sheer number of yet unidentified and potentially threatening viruses, their ability to quickly evolve and transform, their ability to transfer and change from one host organism to another and the difficulty in creating safe vaccines on time.

MAIN BODY

The present review attempts to bring forth the potential risks, prevention and its impact on the global society in terms of sociological and economic parameters. Taking hindsight from previously as well as ongoing current viral epidemics, this article aims to draw a concrete correlation between these viruses in terms of their origin, spread and attempts to compare how much they can affect the population. The study also assesses the worst-case scenarios and the amount of preparedness, required to fight against such pandemics and compares the required amount of preparedness to the current precautions and measures by different governments all across the world.

SHORT CONCLUSION

Learning from the current pandemic, we can implement certain measures to prevent the adverse effects of pandemics in the future and through severe preparedness can combat the challenges brought about by the pandemic.

摘要

背景

已知大多数大流行是由细菌或病毒引起的,其中病毒似乎越来越令人担忧,原因在于尚未识别且可能具有威胁性的病毒数量众多、它们快速进化和变异的能力、从一种宿主生物体传播并转移到另一种宿主生物体的能力以及及时研发安全疫苗的困难。

正文

本综述试图从社会学和经济参数方面阐述潜在风险、预防措施及其对全球社会的影响。借鉴以往及当前正在发生的病毒疫情,本文旨在就这些病毒的起源、传播建立具体关联,并尝试比较它们对人群的影响程度。该研究还评估了最坏情况以及应对此类大流行所需的准备程度,并将所需准备程度与世界各国政府目前采取的预防措施和手段进行比较。

简短结论

从当前的大流行中吸取教训,我们可以实施某些措施来预防未来大流行的不利影响,通过充分准备能够应对大流行带来的挑战。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa9c/8787036/6c7c5bcd2d3a/42269_2022_701_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa9c/8787036/49b81e604f62/42269_2022_701_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa9c/8787036/52acfed8dd7e/42269_2022_701_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa9c/8787036/bf9ed3ef1b2d/42269_2022_701_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa9c/8787036/894859f784ab/42269_2022_701_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa9c/8787036/baada6a702a5/42269_2022_701_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa9c/8787036/38400f02496e/42269_2022_701_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa9c/8787036/124fa7d3e46d/42269_2022_701_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa9c/8787036/37eb58375712/42269_2022_701_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa9c/8787036/ae15ce01a19d/42269_2022_701_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa9c/8787036/a4db10c8021f/42269_2022_701_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa9c/8787036/6c7c5bcd2d3a/42269_2022_701_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa9c/8787036/49b81e604f62/42269_2022_701_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa9c/8787036/52acfed8dd7e/42269_2022_701_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa9c/8787036/bf9ed3ef1b2d/42269_2022_701_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa9c/8787036/894859f784ab/42269_2022_701_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa9c/8787036/baada6a702a5/42269_2022_701_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa9c/8787036/38400f02496e/42269_2022_701_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa9c/8787036/124fa7d3e46d/42269_2022_701_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa9c/8787036/37eb58375712/42269_2022_701_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa9c/8787036/ae15ce01a19d/42269_2022_701_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa9c/8787036/a4db10c8021f/42269_2022_701_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa9c/8787036/6c7c5bcd2d3a/42269_2022_701_Fig11_HTML.jpg

相似文献

1
Cross-species virus transmission and its pandemic potential.跨物种病毒传播及其大流行潜力。
Bull Natl Res Cent. 2022;46(1):18. doi: 10.1186/s42269-022-00701-7. Epub 2022 Jan 25.
2
COVID-19: Prospective Challenges and Potential Vaccines.新型冠状病毒肺炎:潜在挑战与候选疫苗
Altern Ther Health Med. 2020 Aug;26(S2):72-78.
3
Systematic Review of Clinical Insights into Novel Coronavirus (CoVID-19) Pandemic: Persisting Challenges in U.S. Rural Population.新型冠状病毒(COVID-19)大流行的临床洞察系统评价:美国农村人口的持续挑战。
Int J Environ Res Public Health. 2020 Jun 15;17(12):4279. doi: 10.3390/ijerph17124279.
4
The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.在英国和美国,针对成年人的 COVID-19 疫苗副作用风险的描述和沟通对疫苗接种意愿的影响:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Sep 6;22(1):592. doi: 10.1186/s13063-021-05484-2.
5
COVID-19-A Novel Zoonotic Disease: A Review of the Disease, the Virus, and Public Health Measures.COVID-19 新型人畜共患病:疾病、病毒和公共卫生措施综述。
Asia Pac J Public Health. 2020 May;32(4):145-153. doi: 10.1177/1010539520931326. Epub 2020 May 30.
6
Vaccine Innovation for Pandemic Preparedness: Patent Landscape, Global Sustainability, and Circular Bioeconomy in Post-COVID-19 era.大流行防范的疫苗创新:后新冠疫情时代的专利格局、全球可持续性与循环生物经济
Circ Econ Sustain. 2021;1(4):1439-1461. doi: 10.1007/s43615-021-00051-y. Epub 2021 Jul 15.
7
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.新冠病毒-19(Sars-Cov-2)的英国变体不应造成疫苗问题。
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E.
8
Synergistic fight against future pandemics: Lessons from previous pandemics.协同应对未来大流行:既往大流行的教训
Infez Med. 2023 Dec 1;31(4):429-439. doi: 10.53854/liim-3104-2. eCollection 2023.
9
Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.CEPI/BC 2020 年 3 月 12-13 日会议共识总结报告:评估 COVID-19 疫苗引起疾病增强的风险。
Vaccine. 2020 Jun 26;38(31):4783-4791. doi: 10.1016/j.vaccine.2020.05.064. Epub 2020 May 25.
10
An Ophthalmologist's Insight Into The Viral Pandemics.眼科医生对病毒大流行的洞察。
J Optom. 2022 Jan-Mar;15(1):35-43. doi: 10.1016/j.optom.2020.10.005. Epub 2021 Jan 6.

引用本文的文献

1
Genomic surveillance of influenza A virus in live bird markets during the COVID-19 pandemic.新冠疫情期间活禽市场甲型流感病毒的基因组监测
Vet World. 2025 Apr;18(4):955-968. doi: 10.14202/vetworld.2025.955-968. Epub 2025 Apr 23.
2
Assessment for Risk of Possible Human Transmission of FCoV-23.评估猫冠状病毒23型可能发生人际传播的风险。
Transbound Emerg Dis. 2024 Oct 1;2024:8398470. doi: 10.1155/2024/8398470. eCollection 2024.
3
Oral mucosa immunity: ultimate strategy to stop spreading of pandemic viruses.口腔黏膜免疫:阻止大流行病毒传播的终极策略。

本文引用的文献

1
Plague Prevention and Therapy: Perspectives on Current and Future Strategies.鼠疫的预防与治疗:当前及未来策略展望
Biomedicines. 2021 Oct 9;9(10):1421. doi: 10.3390/biomedicines9101421.
2
Review of a controversial treatment method in the fight against COVID-19 with the example of Algeria.以阿尔及利亚为例,回顾抗击新冠疫情中一种有争议的治疗方法。
Bull Natl Res Cent. 2021;45(1):94. doi: 10.1186/s42269-021-00550-w. Epub 2021 May 20.
3
Experts criticise India's complacency over COVID-19.专家批评印度在新冠疫情上的自满态度。
Front Immunol. 2023 Oct 19;14:1220610. doi: 10.3389/fimmu.2023.1220610. eCollection 2023.
4
Global Infection Rate of Rotavirus C during 1980-2022 and Analysis of Critical Factors in the Host Range Restriction of Virus VP4.全球轮状病毒 C 在 1980 年至 2022 年期间的感染率及病毒 VP4 宿主范围限制中关键因素的分析。
Viruses. 2022 Dec 19;14(12):2826. doi: 10.3390/v14122826.
Lancet. 2021 May 1;397(10285):1611-1612. doi: 10.1016/S0140-6736(21)00993-4.
4
COVID-19: Insights into Potential Vaccines.新型冠状病毒肺炎:对潜在疫苗的见解
Microorganisms. 2021 Mar 15;9(3):605. doi: 10.3390/microorganisms9030605.
5
Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment.确保全球公平获得 COVID-19 疫苗面临的挑战:生产、可负担性、分配和部署。
Lancet. 2021 Mar 13;397(10278):1023-1034. doi: 10.1016/S0140-6736(21)00306-8. Epub 2021 Feb 12.
6
SARS-CoV-2: Outline, Prevention, and Decontamination.严重急性呼吸综合征冠状病毒2:概述、预防与消毒
Pathogens. 2021 Jan 23;10(2):114. doi: 10.3390/pathogens10020114.
7
COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far.COVID-19:具有悠久历史、流行病学和迄今进展的全球性挑战。
Molecules. 2020 Dec 23;26(1):39. doi: 10.3390/molecules26010039.
8
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.巴瑞替尼联合瑞德西韦治疗住院的新冠成年患者
N Engl J Med. 2021 Mar 4;384(9):795-807. doi: 10.1056/NEJMoa2031994. Epub 2020 Dec 11.
9
COVID-19 vaccine: A recent update in pipeline vaccines, their design and development strategies.COVID-19 疫苗:管道疫苗的最新更新、设计和开发策略。
Eur J Pharmacol. 2021 Feb 5;892:173751. doi: 10.1016/j.ejphar.2020.173751. Epub 2020 Nov 25.
10
miRNAs in SARS-CoV 2: A Spoke in the Wheel of Pathogenesis.SARS-CoV-2 中的 miRNAs:发病机制之轮上的一个辐条。
Curr Pharm Des. 2021;27(13):1628-1641. doi: 10.2174/1381612826999201001200529.